DARS™ Stock Ratings for MRK

If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Merck (MRK) in this space. Sign up for Dividend.com Premium today to gain access to ratings on nearly 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!

Subscribe to Dividend.com Premium Today! »

Recent Dividend.com Articles for MRK

• Merck's Price Target, Estimates Raised at Barclays Capital (MRK)
  4 hours, 13 minutes ago
• Merck's Price Target Boosted at Deutsche Bank (MRK)
  Fri, Jan 22, 2010
• Market Wrap-Up for Jan.19 (BMY, MRK, X, POT, MMM, more)
  Tue, Jan 19, 2010
• Dividend Stock Leaders and Laggards from the Week of Jan.11-15 (MRK, PFE, WYN, POT, TXN, AA, MOS, more)
  Sat, Jan 16, 2010
• Market Wrap-Up for Jan.14 (INTC, ORCL, IBM, STT, MRK, POT, more)
  Thu, Jan 14, 2010
• Market Wrap-Up for Jan.13 (MRK, INTC, MTB, MEE, X, MS, more)
  Wed, Jan 13, 2010
• Merck Upgraded at Credit Suisse (MRK)
  Wed, Jan 13, 2010
• Market Wrap-Up for Dec.1 (GES, WFC, JPM, MRK, HD, more)
  Tue, Dec 1, 2009
• New Dividend Stock Recommendations - 12/1
  Tue, Dec 1, 2009
• Goldman Sachs Raises Price Target for Merck (MRK)
  Tue, Dec 1, 2009
• Best Large Cap Dividend Stock Prospects List - Nov.28 Edition
  Sat, Nov 28, 2009
• Merck Wins Vioxx Judgment in Texas (MRK)
  Mon, Nov 23, 2009
• Dividend Stock Leaders and Laggards from the Week of Nov.16-20 (MRK, DE, BMY, BVN, CHK, AEO, more)
  Sat, Nov 21, 2009
• Best Large Cap Dividend Stock Prospects List - Nov.21 Edition
  Sat, Nov 21, 2009
• Dividend Highlights and Lowlights for Nov. 20
  Fri, Nov 20, 2009
• Latest Dividend Notes (MRK, NKE, ED, SUN, more)
  Fri, Nov 20, 2009
• Best Large Cap Dividend Stock Prospects List - Nov.14 Edition
  Sat, Nov 14, 2009
• Wall Street Firm Believes Risks are Priced into Merck Shares (MRK)
  Mon, Nov 9, 2009
• Best Large Cap Dividend Stock Prospects List - Nov.7 Edition
  Sat, Nov 7, 2009

Company Profile & Recommendation

Company Profile

Merck (MRK) - pharmaceutical giant's drugs are used in the treatment of cardiovascular ailments, hypertension, high cholesterol, inflammation, glaucoma, ulcers, hepatitis, and Parkinson’s disease. Here are some of the familiar names. It offers Singulair for treating asthma, and relief of symptoms of allergic rhinitis; Cozaar/Hyzaar and Vasotec for the treatment of hypertension/heart failure; Fosamax and Fosamax Plus D for the treatment and prevention of osteoporosis; Zocor, an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, an urology product for the treatment of symptomatic benign prostate enlargement; Maxalt, an acute migraine product; and Propecia for the treatment of male pattern hair loss. The company offers Varivax to prevent chickenpox; M-M-R II, for the treatment of measles, mumps, and rubella; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; Gardasil for the prevention of cervical cancer and genital warts; Pneumovax for the prevention of pneumococcal diseases; RotaTeq for the protection against rotavirus gastroenteritis in infants and children; and Zostavax, a vaccine for the prevention of shingles. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.